Arcellx (NASDAQ:ACLX) Price Target Raised to $100.00
Arcellx (NASDAQ:ACLX – Free Report) had its price objective boosted by Bank of America from $84.00 to $100.00 in a research ...
Arcellx price target raised to $136 from $87 at Truist
Truist raised the firm’s price target on Arcellx (ACLX) to $136 from $87 and keeps a Buy rating on the shares after its Q3 results. The ...
Arcellx Inc’s Anito-cel: Promising CAR-T Therapy with Strategic Partnerships and Strong Financial Position
Leerink Partners analyst Daina Graybosch has maintained their bullish stance on ACLX stock, giving a Buy rating on November 8. Daina ...
ETF Daily News5d
Arcellx (NASDAQ:ACLX) Given New $106.00 Price Target at Robert W. Baird
Arcellx (NASDAQ:ACLX – Free Report) had its target price increased by Robert W. Baird from $77.00 to $106.00 in a research ...
Yahoo Finance6d
Is Arcellx (ACLX) Outperforming Other Medical Stocks This Year?
Is Arcellx, Inc. (ACLX) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
FierceBiotech6h
Gilead lays off 72 workers in Seattle, plans to shutter R&D support site
Roughly a year ago, Gilead Sciences revealed that it was laying off about 7% of Kite Pharma’s workforce in a bid to refresh ...
Nasdaq6d
Analyst Expectations For Arcellx's Future
Across the recent three months, 11 analysts have shared their insights on Arcellx (NASDAQ:ACLX), expressing a variety of opinions spanning from bullish to bearish. The table below provides a ...
Investing6d
Arcellx earnings missed by $0.14, revenue fell short of estimates
Investing.com - Arcellx (NASDAQ: ACLX) reported third quarter EPS of $-0.48, $0.14 worse than the analyst estimate of $-0.34. Revenue for the quarter came in at $26.03M versus the consensus ...